Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,509
Closed -$1.14K 3202
2023
Q3
$1.14K Hold
1,509
﹤0.01% 2676
2023
Q2
$1.1K Hold
1,509
﹤0.01% 2680
2023
Q1
$1.14K Hold
1,509
﹤0.01% 2671
2022
Q4
$1.45K Hold
1,509
﹤0.01% 2594
2022
Q3
$5K Hold
1,509
﹤0.01% 2208
2022
Q2
$5K Buy
+1,509
New +$5.64K ﹤0.01% 2208
2021
Q4
$13K Sell
2,039
-40,746
-95% -$278K ﹤0.01% 1838
2021
Q3
$340K Buy
42,785
+300
+0.7% +$2.47K 0.01% 794
2021
Q2
$318K Buy
42,485
+17,274
+69% +$121K 0.01% 851
2021
Q1
$153K Buy
+25,211
New +$194K 0.01% 1096

Other funds holding VXRT

Harbour Investments's VXRT Position: Q4 2023 in Review

Harbour Investments sold out of Vaxart (VXRT) in Q4 2023, closing a stake of 1,509 shares — an estimated $1.14K sold.

Harbour Investments first reported a position in VXRT in Q1 2021 and held it in 10 quarters. The position peaked at $340K in Q3 2021. 87 funds tracked by Wall St. Rank hold VXRT as of Q4 2023.

  • Harbour Investments reported no remaining Vaxart position as of Q4 2023 after selling out during the quarter.
  • Harbour Investments sold 1,509 Vaxart shares in Q4 2023, an estimated $1.14K.
  • Harbour Investments first reported a position in Vaxart in Q1 2021 and held it in 10 quarters.
  • Harbour Investments's Vaxart position peaked at $340K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Vaxart as of Q4 2023.

Based on Harbour Investments's 13F filing for Q4 2023, filed 16 Feb 2024.